We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.
- Authors
Ball, M Patricia; Warren, Kimberly R; Feldman, Stephanie; McMahon, Robert P; Kelly, Deanna L; Buchanan, Robert W
- Abstract
In recent years, several pharmacological and psychosocial interventions have examined ways to prevent or treat weight gain in people receiving second-generation antipsychotics. While there has been some success, in general, results have not been compelling. Atomoxetine is a selective norepinepherine reuptake inhibitor found to be associated with appetite suppression. Therefore, we examined whether atomoxetine may be of benefit for those who have gained weight on either clozapine or olanzapine.
- Publication
Clinical schizophrenia & related psychoses, 2011, Vol 5, Issue 1, p17
- ISSN
1935-1232
- Publication type
Journal Article
- DOI
10.3371/CSRP.5.1.3